Bone Marrow Transplantation in Treating Patients With Leukemia

Withdrawn before enrolling · Phase 3

Conditions studied: Graft Versus Host Disease, Leukemia, Lymphoma

In brief

RATIONALE: Bone marrow transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill cancer cells. PURPOSE: Randomized phase II/III trial to determine the effectiveness of bone marrow transplantation in treating patients who have leukemia.

Key facts

Study ID

NCT00006451

Run by

Masonic Cancer Center, University of Minnesota

People needed

0

Starts

1996-04-01

Expected to finish

2000-11-01

Last updated by the study team

2020-01-03

Who can join

Age: any, up to 45. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Minnesota Cancer Center — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.